Drug Shortage Report for ACT-HIB
Report ID | 107680 |
Drug Identification Number | 01959034 |
Brand name | ACT-HIB |
Common or Proper name | Haemophilus b Conjugate Vaccine (Tetanus Protein – Conjugate) |
Company Name | SANOFI PASTEUR LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | TETANUS PROTEIN HAEMOPHILUS INFLUENZAE TYPE B-PRP |
Strength(s) | 30MCG 10MCG |
Dosage form(s) | KIT POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR |
Packaging size | 5 x 0.5 mL vials |
ATC code | J07AG |
ATC description | BACTERIAL VACCINES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2020-03-03 |
Actual start date | 2020-03-03 |
Estimated end date | 2020-06-15 |
Actual end date | 2020-05-12 |
Shortage status | Resolved |
Updated date | 2020-05-13 |
Company comments | Shortage due to delays in manufacturing and shipment of product for Canada. Allocation plan in place to meet public market demand. Product not available for private market. Resolved on Wednesday May 13, 2020. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1755 STEELES AVENUE WEST TORONTO, ONTARIO CANADA M2R 3T4 |
Company contact information | Customer Service/Service à la clientèle: 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2020-05-13 | English | Compare |
v5 | 2020-03-04 | French | Compare |
v4 | 2020-03-04 | English | Compare |
v3 | 2020-03-04 | French | Compare |
v2 | 2020-03-04 | French | Compare |
v1 | 2020-03-04 | English | Compare |
Showing 1 to 6 of 6